COVID-19 Roundtable Discussion

Wednesday 24th March 2021

Date: Wednesday 24th March 2021

What to expect from this discussion:

PHASTAR’s COVID-19 Roundtable, taking place Wednesday 24th March, will see our panel of experts, including our CEO, Kevin Kane, our Snr Director of Data Operations, our Director of Biostatistics and our VP of Statistical Research and Consultancy answering your questions on COVID-19; discussing the data, statistics and epidemiology behind the pandemic which has changed our lives for the past year.

Meet the panel

Kevin Kane

Kevin Kane

Founder & CEO

Kevin started his statistical career in 1990 with Amgen. After three years, he moved to Wellcome and stayed in the GSK family of companies for a number of years. Having held a variety of positions, including project statistician and technical support gives Kevin a broad oversight of the clinical trial process. Kevin set up PHASTAR in 2007 and is a Chartered Statistician and a former Board Member for PSI (Statisticians in the Pharmaceutical Industry). He is still actively involved in providing statistical support.

Sheelagh Aird

Sheelagh Aird

Senior Director, Data Operations

With more than 30 years of experience in clinical data management, Sheelagh has directed and delivered projects in all phases of clinical trials across numerous therapeutic areas and data collection platforms. Sheelagh holds a BSc in pharmacology and doctorate in pharmacokinetics from the University of Bath. She has led PHASTAR’s Data Operations group since 2016.

Professor Jennifer Rogers

Professor Jennifer Rogers

VP, Statistical Research & Consultancy

Jen joined PHASTAR as Head of Statistical Research in August 2019, following a move from the University of Oxford where she was Director of Statistical Consultancy Services and an Associate Professor in the Department of Statistics. She had previously worked as a Post-Doctoral Research Fellow in the Department of Statistics funded by the National Institute of Health Research. Formerly Vice President for External Affairs at the RSS and now a member of its COVID-19 task force, Jen directs the statistical research strategy helping the company stay at the cutting edge of new methodological advances.

Dr LaRee Tracy

Dr LaRee Tracy

Director of Biostatistics, San Diego

LaRee has more than 24 years’ experience in clinical research, industry regulation and clinical operations, including over 16 years working as an FDA CDER statistician. Her areas of expertise include biostatistics, experimental and observational study design, as well as significant experience with FDA processes and regulations.

Interested in learning more?

We are experts in study design, statistical analysis, data science, data capture and reporting for clinical trials